SpringWorks Therapeutics, Inc. (SWTX) has an overall financial health rating of C- with a composite score of 1 out of 5.
Component scores: Discounted Cash Flow (DCF): 1/5, Return on Equity (ROE): 1/5, Return on Assets (ROA): 1/5, Debt-to-Equity (D/E): 3/5, Price-to-Earnings (P/E): 1/5, Price-to-Book (P/B): 1/5.
This suggests the company faces some financial challenges worth monitoring. Rating as of 2025-06-30.
| Date | Rating | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | |
| 2025-06-27 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | |
| 2025-06-26 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | |
| 2025-06-25 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | |
| 2025-06-24 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | |
| 2025-06-23 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | |
| 2025-06-20 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | |
| 2025-06-18 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | |
| 2025-06-17 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | |
| 2025-06-16 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | |
| 2025-06-13 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 | |
| 2025-06-12 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
